A detailed history of Simplex Trading, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 35 shares of BIO stock, worth $11,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 3,189 98.9%
Holding current value
$11,952
Previous $870,000 98.74%
% of portfolio
0.0%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$263.97 - $344.64 $832,561 - $1.09 Million
-3,154 Reduced 98.9%
35 $11,000
Q2 2024

Jul 25, 2024

BUY
$268.26 - $339.48 $855,481 - $1.08 Million
3,189 New
3,189 $870,000
Q3 2023

Nov 01, 2023

SELL
$350.25 - $422.63 $101,572 - $122,562
-290 Reduced 65.91%
150 $53,000
Q2 2023

Aug 04, 2023

SELL
$359.49 - $486.4 $190,889 - $258,278
-531 Reduced 54.69%
440 $166,000
Q1 2023

Apr 27, 2023

BUY
$418.69 - $503.0 $96,298 - $115,690
230 Added 31.04%
971 $465,000
Q4 2022

Feb 02, 2023

SELL
$351.71 - $456.01 $492,745 - $638,870
-1,401 Reduced 65.41%
741 $311,000
Q3 2022

Nov 04, 2022

BUY
$412.59 - $563.26 $883,767 - $1.21 Million
2,142 New
2,142 $893,000
Q2 2022

Aug 03, 2022

SELL
$463.67 - $597.16 $133,073 - $171,384
-287 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$524.57 - $735.42 $69,767 - $97,810
133 Added 86.36%
287 $161,000
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $88,802 - $99,952
154 New
154 $99,000
Q1 2021

Apr 26, 2021

SELL
$547.01 - $662.35 $74,393 - $90,079
-136 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$510.68 - $643.45 $69,452 - $87,509
136 New
136 $79,000
Q1 2020

Apr 29, 2020

SELL
$320.01 - $409.07 $268,168 - $342,800
-838 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$319.73 - $374.2 $267,933 - $313,579
838 New
838 $310,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.